medigraphic.com
SPANISH

Revista Mexicana de Angiología

Órgano Oficial de la Sociedad Mexicana de Angiología y Cirugía Vascular
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 3

<< Back Next >>

Rev Mex Angiol 2014; 42 (3)

Determinación del grado de estenosis de la vena subclavia como predictor en el desarrollo de hipertensión venosa en pacientes sometidos a construcción de fístula arteriovenosa autóloga ipsilateral

Serrato-Auld R, Bizueto-Rosas H
Full text How to cite this article

Language: Spanish
References: 25
Page: 119-127
PDF size: 168.47 Kb.


Key words:

Venous stenosis, venous hypertension, AV fistula.

ABSTRACT

Background. The venous hypertension syndrome as a complication of an arteriovenous fistula is linked to ipsilateral central venous stenosis, caused in most cases by hemodialysis catheter placement, which is the inicial vascular access in 77% of patients in México whom start renal function replacement therapy.
Objective. The aim of this study was to determine the degree of subclavian vein stenosis in a preoperative phlebography that can be used to predict venous hypertension development.
Material and methods. A prospective cohort study was done, including 58 patients undergoing construction of AV fistula ipsilateral to the subclavian vein stenosis site that were followed for 6 months with clinical assessment for venous hypertension and vascular access functionality.
Results. 13 of 58 patients developed clinical significant venous hypertension syndrome of which 11 had > 67.5% stenosis, without differences between gender, age, anastomosis diameter, vascular access location or configuration. Only 3 patients required dismantling of AV fistula.
Conclusions. The degree of subclavian vein stenosis may predict the development of clinical significant venous hypertension syndrome when it is greater than 67.5% [PPV 76%, NPV 93.6%, RR 14.24 CI95% (4.69-43.24) p = 0.0000].


REFERENCES

  1. Nevile RF, Abularage CJ, White PW, Sidawy AN. Venous hypertension associated with arteriovenous hemodialysis access. Sem Vasc Surg 2004; 17: 55-6.

  2. Sgroi MD, Patel MS, Wilson SE, Tenning WC, Blebea J, Huber TS. The optimal inicial choice for permanent arteriovenous hemodialysis access. J Vasc Surg 2013; 58: 539-48.

  3. Teruya TH, Abou-Zamazan AM, Limm W, Wong L, Wong L. Symptomatic subclavian vein stenosis and CUADRO IV Tabla de contingencia para estenosis venosa crítica y síndrome de hipertensión venosa clínicamente significativo Sin síndrome de hipertensión venosa Síndrome de hipertensión venosa Total o clínicamente no significativo clínicamente significativo Estenosis de vena subclavia ipsilateral ≤ 67.5% 45 (93.75%) 3 (6.25%) 48 (100%) Estenosis de vena subclavia ipsilateral > 67.5% 1 (9.09%) 10 (90.9%) 11 (100%) Serrato-Auld R y col. Estenosis de la vena subclavia como predictor de hipertensión venosa. Rev Mex Angiol 2014; 42(3): 119-127 127 occlusion in hemodialysis patients with transvenous pacemakers. Ann Vasc Surg 2003; 17: 526-9.

  4. Verstanding AG, Barelowitz D, Zaghar I, Goldin I, Olsha O, Shamieh B, et al. Stent grafts for central venous occlusive disease in patients with ipsilateral hemodialysis access. J Vasc Interv Radiol 2013; 24: 1280-7.

  5. Kundu S. Review of central venous disease in hemodialysis patients. J Vasc Interv Radiol 2010; 21: 963-8.

  6. Lee J, Kim YS, Yoon SA, Kim YS, Won YD, Park SC, et al. Retrospective review of angiography before canulation of newly created vascular access in hemodialysis patients. J Vasc Interv Radiol 2013; 24: 1309-15.

  7. Fokou M, Ashunianiang G, Teyang A, Katze F, Mefire A, Hatle MP. Patients characteristics and outcome of 518 arteriovenous fistulas for hemodialysis in a Sub-Saharan Africam setting. Ann Vasc Surg 2012; 26: 674-9.

  8. Kundu S, Modabber M. Treatment of central venous obstruction in the dialysis patient: patient considerations and treatment options. J Radiol Nurs 2011; 30: 55-61.

  9. Jones RG, Willis AP, Jones C, McCafferty IJ, Riley PL. Long-term results of stent-graft placement to treat central venous stenosis and occlusion in hemodialysis patients with arteriovenous fistulas. J Vasc Interv Radiol 2011; 22: 1240-5.

  10. Bakken AM, Protack CD, Saad WE, Lee DE, Waldman DL, Davies MG. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg 2007; 45: 776-83.

  11. Fokou M, Teyang A, Ashuntantang G, Katze F, Eyenga VC, Mefire AC, et al. Complications of arteriovenous fistula for hemodialysis: An 8 year study. Ann Vasc Surg 2012; 26: 680-4.

  12. Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vasc Surg 2008; 48: 55s-80s.

  13. Agarwal AK. Central Vein stenosis. Am J Kidney Dis 2013; 61: 1001-15.

  14. Méndez A, Méndez JF, Tapia T, Muñoz A, Aguilar L. Epidemiología de la insuficiencia renal crónica en México. Dial Traspl 2010; 31(1): 7-11.

  15. López-Cervantes M, Rojas-Russell ME, Tirado-Gómez LL, Durán-Arenas L, Pacheco-Domínguez RL, Venado- Estrada AA, et al. Enfermedad renal crónica y su atención mediante tratamiento sustitutivo en México. Facultad de Medicina 2010. Universidad Nacional Autónoma de México. Disponible en: http://www.dged.salud.gob.mx/ contenidos/dged/descargas/ERC-4may.pdf

  16. Macsata RA, Sidawy AN. Hemodialysis Access: General Considerations. In: Cronenwett JL, Johnston KW (eds.). Rutherford’s Vascular Surgery. 7a ed. Philadelphia: Saunders; 2010, p. 1104-14.

  17. Dosluoglu HH, Harris LM. Hemodialysis access: nonthrombotic complications. In: Cronenwett JL, Johnston KW (eds.). Rutherford’s Vascular Surgery. 7a ed. Philadelphia: Saunders; 2010, p. 1137-54.

  18. Quinn B, Cull DL, Carsten CG. Hemodialysis access: placement and management of complications. In: Hallett JW, Mills JL, Earnshaw JJ, Reekers JA, Rooke TW (eds.). Comprehensive vascular and endovascular surgery. 2a ed. EUA: Elsevier; 2009, p. 429-62.

  19. Sidawy AN, Spergel LM, Besarab A, Allon M, Jenning WC, Padber FF. The Society for Vascular Surgey: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008; 48: 2s-25s.

  20. Mickley V. Central vein obstruction in vascular access. EJVES 2006; 32: 439-44.

  21. Dammers R, De Haan MW, Planken NR, Van del Sande FM, Tordoir JM. Central vein obstruction in hemodialysis patients. Resuts of radiological and surgical intervention. EJVES 2003; 26: 317-21.

  22. Shingarev R, Barker-Finkel J, Allon M. Association of hemodialysis central venous catheter use with ipsilateral arteriovenous vascular access survival. Am J Kidney Dis 2012; 60(6): 983-9.

  23. Ters ME, Schears GJ, Taler SJ, Williams AW, Albrigth RC, Jenson BM, et al. Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case control study in hemodialysis patients. Am J Kidney Dis 2012; 60(4): 601-8.

  24. Gutiérrez JP, Rivera J, Shamah T, Villalpando S, Franco A, Cuevas L. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales, México: Instituto Nacional de Salud Pública 2012. Disponible en: http://www. ensanut.insp.mx/informes/ENSANUT2012Resultados Nacionales.pdf

  25. Venado-Estrada A, Moreno-López JA, Rodríguez-Alvarado M, MPSS, López-Cervantes M. Unidad de proyectos especiales. Universidad Nacional Autónoma de México. Disponible en: http://www.facmed.unam.mx/sms/temas/ 2009/02_feb_2k9.pdf




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Angiol. 2014;42